Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Ann N Y Acad Sci ; 1362: 200-14, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26662721

ABSTRACT

We propose that there is a special B-1a B cell subset ("sB-1a" cells) that mediates linked processes very early after immunization to initiate cutaneous contact sensitivity (CS), delayed-type hypersensitivity (DTH), and immune resistance to pneumococcal pneumonia. Our published data indicate that in CS and DTH, these initiating processes are required for elicitation of the delayed onset and late-occurring classical T cell-mediated responses. sB-1a cells resemble memory B2 cells, as they are stimulated within 1 h of immunization and depend on T helper cytokines-uniquely IL-4 from hepatic iNKT cells--for activation and rapid migration from the peritoneal cavity to the spleen to secrete IgM antibody (Ab) and Ab-derived free light chains (FLCs) by only 1 day after immunization. Unlike conventional B-1a (cB-1a) cell-produced IgM natural Ab, IgM Ab produced by sB-1a cells has high Ag affinity owing to immunoglobulin V-region mutations induced by activation-induced cytidine deaminase (AID). The dominant cB-1a cells are increased in immunized AID-deficient mice but do not mediate initiation, CS, or pneumonia resistance because natural Ab has relatively low Ag affinity because of unmutated germ-line V regions. In CS and DTH, sB-1a IgM Ag affinity is sufficiently high to mediate complement activation for generation of C5a that, together with vasoactive mediators such as TNF-α released by FLC-sensitized mast cells, activate local endothelium for extravascular recruitment of effector T cells. We conclude by discussing the possibility of functional sB-1 cells in humans.


Subject(s)
B-Lymphocyte Subsets/immunology , Cytidine Deaminase/immunology , Dermatitis, Contact/immunology , Pneumonia, Pneumococcal/immunology , Animals , B-Lymphocyte Subsets/metabolism , Cytidine Deaminase/deficiency , Dermatitis, Contact/metabolism , Humans , Hypersensitivity , Immunization , Mast Cells/immunology , Mast Cells/metabolism , Mice , Pneumonia, Pneumococcal/prevention & control
2.
J Immunol ; 175(11): 7170-8, 2005 Dec 01.
Article in English | MEDLINE | ID: mdl-16301620

ABSTRACT

Elicitation of contact sensitivity (CS), a classic example of T cell-mediated immunity, requires Ag-specific IgM Abs to trigger an initiation process. This early process leads to local recruitment of CS-effector T cells after secondary Ag challenge. These Abs are produced by the B-1 subset of B cells within 1 day after primary skin immunization. In this study we report the surprising observation that B-1 cells in the peritoneal cavity are activated as early as 1 h after naive mice are painted with a contact-sensitizing Ag on the skin of the trunk and feet to begin the initiation of CS. B-1 cells in the spleen and draining lymph nodes produce the initiating Abs by 1 day after immunization, when we found increased numbers of Ag-specific IgM Ab-producing cells in these tissues by ELISPOT assay. Importantly, we show that contact-activated peritoneal B-1 cells migrate to these lymphoid tissues and then differentiate into Ag-specific IgM Ab-producing cells, resulting in specific CS-initiating IgM Abs in the serum by 1 day. Furthermore, pertussis toxin, which is known to inhibit signaling via G protein-coupled chemokines, inhibited the migration of contact-activated peritoneal B-1 cells to the lymphoid tissues, probably due to BLR-1 (Burkitt lymphoma receptor-1). These findings indicate that within 1 h after contact skin immunization, B-1 cells in the peritoneal cavity are activated to migrate to the lymphoid tissues by chemokine-dependent mechanisms to produce serum Ag-specific IgM Abs within 1 day after immunization, leading to local recruitment of CS-effector T cells.


Subject(s)
B-Lymphocytes/immunology , Dermatitis, Contact/immunology , Immunoglobulin M/blood , Lymphocyte Activation/immunology , Peritoneal Cavity/cytology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/drug effects , Cell Differentiation/immunology , Cell Movement/drug effects , Cell Movement/immunology , Immunoglobulin M/biosynthesis , Lymphoid Tissue/immunology , Male , Mice , Models, Immunological , Pertussis Toxin/pharmacology , Time Factors
3.
Immunology ; 113(2): 234-45, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15379984

ABSTRACT

Contact skin immunization of mice with reactive hapten antigen and subsequent airway challenge with the same hapten induces immediate airflow obstruction and subsequent airway hyper-reactivity (AHR) to methacholine challenge, which is dependent on B cells but not on T cells. This responsiveness to airway challenge with antigen is elicited as early as 1 day postimmunization and can be adoptively transferred to naïve recipients via 1-day immune cells. Responses are absent in 1-day immune B-cell-deficient JH(-/-) mice and B-1 B-cell-deficient xid male mice, as well as in recipients of 1-day immune cells depleted of cells with the B-1 cell phenotype (CD19(+) B220(+) CD5(+)). As B-1 cells produce immunoglobulin M (IgM), we sought and found significantly increased numbers of anti-hapten IgM-producing cells in the spleen and lymph nodes of 1-day immune wild-type mice, but not in xid mice. Then, we passively immunized naive mice with anti-hapten IgM monoclonal antibody and, following airway hapten challenge of the recipients, we showed both immediate airflow obstruction and AHR. In addition, AHR was absent in complement C5 and C5a receptor-deficient mice. In summary, this study of the very early elicited phase of a hapten asthma model suggests, for the first time, a role of B-1 cells in producing IgM to activate complement to rapidly mediate asthma airway reactivity only 1 day after immunization.


Subject(s)
Asthma/immunology , B-Lymphocytes/immunology , Bronchial Hyperreactivity/immunology , Complement C5a/immunology , Immunoglobulin M/immunology , Animals , Asthma/pathology , Asthma/physiopathology , Bronchial Hyperreactivity/pathology , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Disease Models, Animal , Female , Haptens/immunology , Immunization/methods , Lung/pathology , Male , Methacholine Chloride/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred CBA , Respiratory Function Tests , Respiratory System
4.
Oncogene ; 22(41): 6369-76, 2003 Sep 25.
Article in English | MEDLINE | ID: mdl-14508517

ABSTRACT

Chronic irradiation of human or murine epidermis with ultraviolet B (UVB) induces clones of p53-mutant keratinocytes. Clones precede and parallel the induction of carcinomas, suggesting that they are an early stage of UVB carcinogenesis. In the absence of UVB, these clones rapidly regress. For UVB-induced murine skin tumors and papillomas, regression is known to involve antigen-specific immunity. To determine whether antigen-specific immunity influences the creation, expansion, or regression of p53-mutant clones, we studied Rag1 knockout mice deficient in the recombination activating gene 1 required for development of B, alphabetaT, gammadeltaT, and natural killer T cells. Since tissue homeostasis could affect proliferation or persistence of clones, we also examined the effect of Rag1 on UVB-induced hyperplasia and apoptosis. Mice were irradiated with UVB daily for 7-11 weeks to create p53-mutant clones, and then retained in the absence of UV. After UV ended, epidermal thickness decreased and p53-mutant clones observed in the epidermal sheets regressed, with no significant differences between Rag1(-/-) and wild type. During the initial chronic UVB irradiation, increasing irradiation time increased both the number and size of p53-mutant clones, with no significant difference between genotypes. We conclude that antigen-specific immunity is not involved in the initiation, expansion, or acute regression of p53-mutant clones.


Subject(s)
Immune System/metabolism , Tumor Suppressor Protein p53/genetics , Animals , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Mice , Mice, Knockout , Mutation , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Protein p53/radiation effects , Ultraviolet Rays
5.
J Exp Med ; 196(10): 1277-90, 2002 Nov 18.
Article in English | MEDLINE | ID: mdl-12438420

ABSTRACT

Contact sensitivity (CS) is a classic example of in vivo T cell immunity in which skin sensitization with reactive hapten leads to immunized T cells, which are then recruited locally to mediate antigen-specific inflammation after subsequent skin challenge. We have previously shown that T cell recruitment in CS is triggered by local activation of complement, which generates C5a that triggers C5a receptors most likely on mast cells. Here, we show that B-1 cell-derived antihapten IgM antibodies generated within 1 day (d) of immunization combine with local challenge antigen to activate complement to recruit the T cells. These findings overturn three widely accepted immune response paradigms by showing that (a) specific IgM antibodies are required to initiate CS, which is a classical model of T cell immunity thought exclusively due to T cells, (b) CS priming induces production of specific IgM antibodies within 1 d, although primary antibody responses typically begin by day 4, and (c) B-1 cells produce the 1-d IgM response to CS priming, although these cells generally are thought to be nonresponsive to antigenic stimulation. Coupled with previous evidence, our findings indicate that the elicitation of CS is initiated by rapidly formed IgM antibodies. The IgM and challenge antigen likely form local complexes that activate complement, generating C5a, leading to local vascular activation to recruit the antigen-primed effector T cells that mediate the CS response.


Subject(s)
Autoantibodies/immunology , B-Lymphocytes/immunology , Dermatitis, Contact/immunology , Immunoglobulin M/immunology , T-Lymphocytes/immunology , Animals , Cell Separation , Complement C5/immunology , Flow Cytometry , Male , Mice , Mice, Inbred CBA
6.
J Immunol ; 169(8): 4113-23, 2002 Oct 15.
Article in English | MEDLINE | ID: mdl-12370339

ABSTRACT

The elicitation of contact sensitivity (CS) to local skin challenge with the hapten trinitrophenyl (TNP) chloride requires an early process that is necessary for local recruitment of CS-effector T cells. This is called CS initiation and is due to the B-1 subset of B cells activated at immunization to produce circulating IgM Ab. At challenge, the IgM binds hapten Ag in a complex that locally activates C to generate C5a that aids in T cell recruitment. In this study, we present evidence that CS initiation is indeed mediated by C-activating classic IgM anti-TNP pentamer. We further demonstrate the involvement of IgM subunits derived either from hybridomas or from lymphoid cells of actively immunized mice. Thus, reduced and alkylated anti-TNP IgM also initiates CS, likely due to generated H chain-L chain dimers, as does a mixture of separated H and L chains that still could weakly bind hapten, but could not activate C. Remarkably, anti-TNP kappa L chains alone mediated CS initiation that was C-independent, but was dependent on mast cells. Thus, B-1 cell-mediated CS initiation required for T cell recruitment is due to activation of C by specific IgM pentamer, and also subunits of IgM, while kappa L chains act via another C-independent but mast cell-dependent pathway.


Subject(s)
B-Lymphocyte Subsets/pathology , Complement System Proteins/physiology , Dermatitis, Contact/immunology , Immunoglobulin M/metabolism , Immunoglobulin kappa-Chains/physiology , T-Lymphocyte Subsets/immunology , Animals , Binding Sites, Antibody/genetics , Complement Activation/genetics , Complement Activation/immunology , Dermatitis, Contact/genetics , Dimerization , Ear, External/immunology , Edema/genetics , Edema/immunology , Female , Haptens/metabolism , Immunoglobulin Heavy Chains/administration & dosage , Immunoglobulin Heavy Chains/isolation & purification , Immunoglobulin Heavy Chains/pharmacology , Immunoglobulin M/administration & dosage , Immunoglobulin kappa-Chains/administration & dosage , Immunoglobulin kappa-Chains/isolation & purification , Immunoglobulin kappa-Chains/pharmacology , Injections, Intravenous , Lymphopenia/genetics , Lymphopenia/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Inbred DBA , Mice, Mutant Strains , Protein Subunits , Trinitrobenzenes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...